Trials / Unknown
UnknownNCT03892694
Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Characterizing the Mechanism of Action of Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- CSA Medical, Inc. · Industry
- Sex
- All
- Age
- 40 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the relationship between airway structure and function in patients with chronic bronchitis treated with metered cryospray (MCS).
Detailed description
To identify the molecular and cellular targets of MCS treatment and determine the mechanistic relationship to airways remodelling in patients with chronic bronchitis. Phenotype, characterise and correlate clinical, physiological, histological and molecular parameters in patients with chronic bronchitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RejuvenAir System | Bronchial metered cryospray using RejuvenAir® System. |
| OTHER | Sham | Sham control procedure |
Timeline
- Start date
- 2020-02-14
- Primary completion
- 2022-07-11
- Completion
- 2024-06-01
- First posted
- 2019-03-27
- Last updated
- 2024-02-23
Locations
2 sites across 2 countries: Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT03892694. Inclusion in this directory is not an endorsement.